Cargando…
BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups
Langerhans cell histiocytosis (LCH) is a clonal disorder with elusive etiology, characterized by the accumulation of CD207(+) dendritic cells (DCs) in inflammatory lesions. Recurrent BRAF-V600E mutations have been reported in LCH. In this study, lesions from 100 patients were genotyped, and 64% carr...
Autores principales: | Berres, Marie-Luise, Lim, Karen Phaik Har, Peters, Tricia, Price, Jeremy, Takizawa, Hitoshi, Salmon, Hélène, Idoyaga, Juliana, Ruzo, Albert, Lupo, Philip J., Hicks, M. John, Shih, Albert, Simko, Stephen J., Abhyankar, Harshal, Chakraborty, Rikhia, Leboeuf, Marylene, Beltrão, Monique, Lira, Sérgio A., Heym, Kenneth M., Clausen, Björn E., Bigley, Venetia, Collin, Matthew, Manz, Markus G., McClain, Kenneth, Merad, Miriam, Allen, Carl E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978272/ https://www.ncbi.nlm.nih.gov/pubmed/24638167 http://dx.doi.org/10.1084/jem.20130977 |
Ejemplares similares
-
BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups
por: Berres, Marie-Luise, et al.
Publicado: (2015) -
RAF/MEK/extracellular signal–related kinase pathway suppresses dendritic cell migration and traps dendritic cells in Langerhans cell histiocytosis lesions
por: Hogstad, Brandon, et al.
Publicado: (2018) -
Hepatic Langerhans Cell Histiocytosis (LCH) Presenting as a Harbinger of Multisystem LCH
por: Li, Hua, et al.
Publicado: (2020) -
Light Composite Higgs: LCH@LHC
por: Sannino, F
Publicado: (2005) -
Salvage treatment of relapsed/refractory LCH
por: Seo, Jong Jin
Publicado: (2016)